SEC 13F Intelligence

Endurant Capital Management LP / TXG

Endurant Capital Management LP’s 10x Genomics Inc Position

Does Endurant Capital Management LP own 10x Genomics Inc (TXG)? Not currently — the last reported position was 71.0K shares worth $3M in Q3 2023; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$3M
Q3 2023
Shares
71.0K
% of Portfolio
+2.63%
Quarters Held
3
position exited

Position History TXG

Reported value by quarter
Q1 ’22: $2MQ1 ’22Q4 ’22: $1MQ4 ’22Q3 ’23: $3MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202371.0K$3M+2.63%
Q4 202230.4K$1M+0.45%
Q1 202224.9K$2M+0.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of TXG.